XWEL
XWELL, Inc.
Diagnostics & Research · Healthcare · United States
0.69
close · 2026-10-30
value
2
cheaper than peers2
quality
2
stronger fundamentals2
ranked against
Diagnostics & Research
value
quality
31 peers
Value inputs
| measure | company | vs peers |
| price to sales | 0.24× | 98 |
| price to book | 18.47× | 19 |
| earnings yield, 1 year ago | -530.4% | 2 |
| earnings yield, 2 years ago | -962.2% | 2 |
| cash flow yield, latest year | -169.7% | 2 |
| cash flow yield, 2 years ago | -268.1% | 2 |
| cash flow yield, 3 years ago | -450.9% | 2 |
| cash flow yield, 1 year ago | -186.0% | 2 |
| earnings yield, latest year | -736.1% | 2 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 88.4% | 26 |
| operating margin | -26.1% | 15 |
| revenue growth | -7.1% | 8 |
| return on equity | -361.4% | 2 |
4 of 4 measures available
Facts
| market cap | $7M |
| free cash flow | -$9.1M |
| employees | 175 |
| first trade | 2010-07-27 |
| next earnings | not reported |
| fundamentals updated | 2026-08-21 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -5.08 | -3.66 | -6.64 | -7.01 |
| free cash flow | -$11.7M | -$12.8M | -$18.4M | -$31.0M |
| net income | -$17.0M | -$16.9M | -$27.7M | -$32.8M |
| revenue | $29.2M | $33.9M | $30.1M | $55.9M |
| unusual items | -$3.8M | -$4.5M | -$8.8M | -$7.9M |